Form 8-K - Current report:
SEC Accession No. 0001140361-21-008135
Filing Date
2021-03-11
Accepted
2021-03-11 09:12:12
Documents
2
Period of Report
2021-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nt10021594x3_8k.htm 8-K 25124
2 EXHIBIT 99.1 nt10021594x3_ex99-1.htm EX-99.1 103739
  Complete submission text file 0001140361-21-008135.txt   130230
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 21732037
SIC: 2834 Pharmaceutical Preparations